Genetic Mediators of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia
- 10 June 2013
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 31 (17) , 2182-2188
Abstract
Purpose: Survivors of childhood acute lymphoblastic leukemia (ALL) are at increased risk for neurocognitive problems, with significant interindividual variability in outcome. This study examined genetic polymorphisms associated with variability in neurocognitive outcome. Patients and Methods: Neurocognitive outcomes were evaluated at the end of therapy in 243 survivors treated on an institutional protocol featuring risk-adapted chemotherapy without prophylactic cranial irradiation. Polymorphisms in genes related to pharmacokinetics or pharmacodynamics of antileukemic agents, drug metabolism, oxidative stress, and attention problems in noncancer populations were examined as predictors of outcome, using multiple general linear models and controlling for age at diagnosis, sex, race, and treatment intensity. Results: Compared with national norms, the cohort demonstrated significantly higher rates of problems on direct assessment of sustained attention (P = .01) and on parent ratings of attention problems (P = .02). Children with the A2756G polymorphism in methionine synthase (MS) were more likely to demonstrate deficits in attentiveness (P = .03) and response speed (P = .02), whereas those with various polymorphisms in glutathione S-transferase demonstrated increased performance variability (P = .01) and reduced attentiveness (P = .003). Polymorphisms in monoamine oxidase (T1460CA) were associated with increased attention variability (P = .03). Parent-reported attention problems were more common in children with the Cys112Arg polymorphism in apoliopoprotein E4 (P = .01). Conclusion: These results are consistent with our previous report of association between attention problems and MS in an independent cohort of long-term survivors of childhood ALL treated with chemotherapy only. The results also raise the possibility of an impact from genetic predispositions related to oxidative stress and CNS integrity.Keywords
This publication has 43 references indexed in Scilit:
- Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapyPediatric Blood & Cancer, 2011
- Age-related differences in white matter integrity and cognitive function are related to APOE statusNeuroImage, 2011
- APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general populationLipids in Health and Disease, 2010
- APOE ε4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donorsAIDS, 2010
- Neurocognitive Functioning in Adult Survivors of Childhood Non-Central Nervous System CancersJNCI: Journal of the National Cancer Institute, 2010
- Sensory over-responsivity and ADHD: differentiating using electrodermal responses, cortisol, and anxietyFrontiers in Integrative Neuroscience, 2010
- Comparison of Neurocognitive Functioning in Children Previously Randomly Assigned to Intrathecal Methotrexate Compared With Triple Intrathecal Therapy for the Treatment of Childhood Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2009
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial IrradiationNew England Journal of Medicine, 2009
- Neuroimaging correlates of parent ratings of working memory in typically developing childrenJournal of the International Neuropsychological Society, 2009
- Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of strokeNeurological Sciences, 2004